CLUVOT

This brand name is authorized in Spain, Finland, Malta, Netherlands, Poland, Romania

Active ingredients

The drug CLUVOT contains one active pharmaceutical ingredient (API):

1 Coagulation factor XIII UNII F7R0FBC1XD - FACTOR XIII CONCENTRATE (HUMAN)

Factor XIII connects the amino group of lysine with glutamine via its enzymatic function (transamidase activity), thereby leading to the cross-linking of fibrin molecules. This is the final stage of blood coagulation. Fibrin cross-linking and stabilisation promote the penetration of fibroblasts and support wound healing. Read about Coagulation factor XIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD07	Coagulation factor XIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 78779
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 453809, 539484
Country: MT	Medicines Authority	Identifier(s): MA665/00201, MA665/00202
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 119059, 119067
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100322841, 100322858
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W61352001, W61353001